Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2000
06/22/2000CA2351469A1 Method and composition for the maintenance and restitution of gut integrity
06/22/2000CA2351464A1 3,4-diamino-3-cyclobutene-1,2-dione derivatives which inhibit leukocyte adhesion mediated by vla-4
06/22/2000CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2345752A1 Tricyclic nitrogen heterocycles as pde iv inhibitors
06/21/2000EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms
06/21/2000EP1010430A1 Preventives and ameliorating agents for periodontosis
06/21/2000EP1010424A1 Liver fat accumulation inhibitory composition, food additive for liver fat accumulation inhibition, and method of inhibiting liver fat accumulation
06/21/2000EP1010423A2 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
06/21/2000EP1010374A1 Fibre blend for enteral composition
06/21/2000EP1010372A2 Bakery products comprising live lyophilised lactic bacteria
06/21/2000EP1009748A1 3-ALKYLPYRROLO 3,2-$i(c)]QUINOLINE DERIVATIVES
06/21/2000EP1009743A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
06/21/2000EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
06/21/2000EP1009732A2 1-amino-alkylcyclohexane nmda receptor antagonists
06/21/2000EP1009524A1 Improvements in or relating to capsules
06/21/2000EP1009426A1 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
06/21/2000EP1009418A1 Robinia pseudoacacia lectin and its uses
06/21/2000EP1009402A4 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
06/21/2000EP1009402A1 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents
06/21/2000EP1009399A1 Gaba analogs to prevent and treat gastrointestinal damage
06/21/2000DE19858463A1 Verwendung eines Fibrinklebers zur Regeneration des Lebergewebes Use of fibrin glue for the regeneration of liver tissue
06/21/2000DE19858331A1 Tricyclische Stickstoffheterocyclen als PDE IV Inhibitoren Tricyclic nitrogen heterocycles as PDE IV inhibitors
06/21/2000CN1257538A Short peptides which selectively modulate the activity of serine/threonine kinases
06/21/2000CN1257505A Fused dihydropyrans
06/21/2000CN1257500A 9-azabicyclo (3,3,1) non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors
06/21/2000CN1257425A Gastroretentive controlled release microspheres for improved drug delivery
06/21/2000CN1256947A Physical constitution and food and drink health care capsule and productive method thereof
06/21/2000CN1053579C Capsule for treating gastric diseases
06/21/2000CN1053576C Xiebiting medical powder for curing disease of intestines and stomach and preparation thereof
06/21/2000CN1053574C Capsule for treating hepatitis
06/21/2000CN1053572C Application of oxidized matrine in preparing medicine for treatment of hapatitis B
06/20/2000US6077864 Cyclic sulfone derivatives
06/20/2000US6077846 Epibatidine and derivatives thereof as cholinergic receptor agonists and antagonists
06/20/2000US6077830 Bismuth salts of antibiotics of the moenomycin group, processes for their preparation, their use and pharmaceuticals comprising such salts
06/20/2000US6077706 Helicobacter pylori proteins useful for vaccines and diagnostics
06/20/2000US6077541 Enteric coating; capsules
06/20/2000US6077528 Percutaneous preparation
06/20/2000US6077524 Gastric acid binding chewing pastilles
06/20/2000CA2215659C Morphinan hydroxamic acid compounds
06/20/2000CA2198536C Method of reducing tissue damage associated with ischemia
06/18/2000CA2292481A1 Use of fibrin adhesive for tissue regeneration
06/15/2000WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000WO2000034485A2 Beta-1,3-galactosyltransferase homologs
06/15/2000WO2000034468A2 Muc-1 antagonists and methods of treating immune disorders
06/15/2000WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
06/15/2000WO2000034332A1 Glp-1 analogues
06/15/2000WO2000034331A2 Analogues of glp-1
06/15/2000WO2000034313A1 Procollagen c-proteinase inhibitors
06/15/2000WO2000034303A1 METHODS OF MODULATING TUMOR NECROSIS FACTOR α-INDUCED EXPRESSION OF CELL ADHESION MOLECULES
06/15/2000WO2000034285A2 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
06/15/2000WO2000034284A1 2,5-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses
06/15/2000WO2000034281A1 Methotrexate derivatives
06/15/2000WO2000034279A1 1,4-diazabicyclo[3.2.2]nonane derivatives, their preparation and therapeutic application
06/15/2000WO2000034254A1 Novel compounds
06/15/2000WO2000034248A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000WO2000034244A1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
06/15/2000WO2000034243A1 N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
06/15/2000WO2000034230A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction
06/15/2000WO2000034228A1 Ion channel modulating agents
06/15/2000WO2000033876A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
06/15/2000WO2000033854A1 Preparation that contains oligosaccharides and probiotics
06/15/2000WO2000033838A1 Vitronectin receptor antagonist
06/15/2000WO2000033834A1 Use of isatin derivatives as ion channel activating agents
06/15/2000WO2000033828A1 Agent for lowering endothelin levels
06/15/2000WO2000011000A3 New compounds
06/15/2000WO2000009711A3 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
06/15/2000WO1999055858A3 Human nucleic acid sequences obtained from pancreas tumor tissue
06/15/2000WO1999045016A3 Novel prodrugs for phosphorus-containing compounds
06/15/2000WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2000DE19857009A1 Zubereitung mit verbesserter therapeutischer Breite, enthaltend Nukleotidsyntheseinhibitoren Preparation with improved therapeutic index containing nucleotide synthesis
06/15/2000CA2778047A1 Analogues of glp-1
06/15/2000CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000CA2354644A1 Muc-1 antagonists and methods of treating immune disorders
06/15/2000CA2354266A1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors
06/15/2000CA2354026A1 Beta-1,3-galactosyltransferase homologs
06/15/2000CA2353839A1 Methotrexate derivatives
06/15/2000CA2353415A1 Vitronectin receptor antagonist
06/15/2000CA2352740A1 Procollagen c-proteinase inhibitors
06/15/2000CA2350888A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction
06/15/2000CA2350590A1 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
06/15/2000CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/14/2000EP1008344A2 The new use of dicaffeoylquinic acid for treating hepatitis b and the diseases related with retrovirus, and the new caffeoylquinic acid derivatives
06/14/2000EP1007668A1 Human pancreatitis-associated protein, pap-2
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007552A2 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
06/14/2000EP1007528A2 Robustaflavone, intermediates and analogues and method for preparation thereof
06/14/2000EP1007522A1 2- 4-[4-(4, 5-dichloro -2-methylimidazol-1-yl) butyl]-1-piperazinyl -5-fluoropyrimidine,preparation and therapeutic use
06/14/2000EP1007520A1 2-aminopyridines containing fused ring substituents as nos inhibitors
06/14/2000EP1007512A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
06/14/2000EP1007086A1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection
06/14/2000EP1007058A1 USE OF $i(N)-SUBSTITUTED-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS IN COMBINATION THERAPY FOR TREATING HEPATITIS VIRUS INFECTIONS
06/14/2000EP1007056A1 Method for the treatment of cystic fibrosis
06/14/2000EP1007047A1 Use of mizolastine for preparing a medicine for treating inflammation
06/14/2000EP1007033A1 Lymphocyte function antigen-1 antagonists
06/14/2000CN1256145A Chinese medicine composition for treating toothache
06/14/2000CN1256144A Chronic gastritis treating medicine
06/14/2000CN1256129A Application of burr and licorice seeds in medicine
06/14/2000CN1053441C Compound with 1-(aryl china olefine)-4-(aryl methyl) piperazine structure, its preparation process and medicine containing the compound thereof
06/14/2000CN1053438C Benzodiazepin-2-one derivatives, process for their prepn. and pharmaceutical composition containing them
1 ... 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 ... 1258